189 related articles for article (PubMed ID: 16007190)
61. HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.
Gao Y; Yan Y; Guo J; Zhang Q; Bi D; Wang F; Chang Z; Lu L; Yao X; Wei Q
Oncol Rep; 2019 Sep; 42(3):1066-1074. PubMed ID: 31322246
[TBL] [Abstract][Full Text] [Related]
62. Paclitaxel/Taxol sensitivity in human renal cell carcinoma is not determined by the p53 status.
Reinecke P; Kalinski T; Mahotka C; Schmitz M; Déjosez M; Gabbert HE; Gerharz CD
Cancer Lett; 2005 May; 222(2):165-71. PubMed ID: 15863265
[TBL] [Abstract][Full Text] [Related]
63. Expression of lumbosacral HOX genes, crucial in kidney organogenesis, is systematically deregulated in clear cell kidney cancers.
Cantile M; Schiavo G; Franco R; Cindolo L; Procino A; D'Armiento M; Facchini G; Terracciano L; Botti G; Cillo C
Anticancer Drugs; 2011 Jun; 22(5):392-401. PubMed ID: 21403516
[TBL] [Abstract][Full Text] [Related]
64. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.
Duns G; van den Berg A; van Dijk MC; van Duivenbode I; Giezen C; Kluiver J; van Goor H; Hofstra RM; van den Berg E; Kok K
Genes Chromosomes Cancer; 2013 Feb; 52(2):165-73. PubMed ID: 23074016
[TBL] [Abstract][Full Text] [Related]
65. HNF4α induced chemosensitivity to oxaliplatin and 5-FU mediated by OCT1 and CNT3 in renal cell carcinoma.
Hagos Y; Wegner W; Kuehne A; Floerl S; Marada VV; Burckhardt G; Henjakovic M
J Pharm Sci; 2014 Oct; 103(10):3326-34. PubMed ID: 25175346
[TBL] [Abstract][Full Text] [Related]
66. [Significance of oncogenes and growth factors in hypernephroma].
Peter S
Urologe A; 1992 Jan; 31(1):24-7. PubMed ID: 1553800
[TBL] [Abstract][Full Text] [Related]
67. [Establishment of two renal cancer cell lines].
Muraki J; Sugaya Y; Kobayashi M; Hashimoto S; Morita T; Kobayashi Y; Tokue A; Nakazono M
Hinyokika Kiyo; 1997 Mar; 43(3):177-83. PubMed ID: 9127751
[TBL] [Abstract][Full Text] [Related]
68. Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples.
Raimondo F; Morosi L; Chinello C; Perego R; Bianchi C; Albo G; Ferrero S; Rocco F; Magni F; Pitto M
Mol Biosyst; 2012 Apr; 8(4):1007-16. PubMed ID: 22159573
[TBL] [Abstract][Full Text] [Related]
69. Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF- β 1 activation and reduces regulatory ID gene expression.
Notohamiprodjo S; Djafarzadeh R; Rieth N; Hofstetter M; Jaeckel C; Nelson PJ
Biol Chem; 2012 Dec; 393(12):1463-70. PubMed ID: 23667903
[TBL] [Abstract][Full Text] [Related]
70. Screening of feature genes of the renal cell carcinoma with DNA microarray.
Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
[TBL] [Abstract][Full Text] [Related]
71. Cytogenetic and molecular correlates between rodent and human renal cell carcinoma.
Walker C; Recio L; Funaki K; Everitt J
Prog Clin Biol Res; 1992; 376():289-302. PubMed ID: 1528923
[TBL] [Abstract][Full Text] [Related]
72. Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.
Tanaka T; Kondo S; Iwasa Y; Hiai H; Toyokuni S
Am J Pathol; 2000 Jun; 156(6):2149-57. PubMed ID: 10854235
[TBL] [Abstract][Full Text] [Related]
73. From development to cancer: lessons from the kidney to uncover new therapeutic targets.
Dormoy V; Jacqmin D; Lang H; Massfelder T
Anticancer Res; 2012 Sep; 32(9):3609-17. PubMed ID: 22993298
[TBL] [Abstract][Full Text] [Related]
74. Transcriptome network analysis reveals candidate genes for renal cell carcinoma.
Zhai W; Xu YF; Liu M; Zheng JH
J Cancer Res Ther; 2012; 8(1):28-33. PubMed ID: 22531510
[TBL] [Abstract][Full Text] [Related]
75. Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line.
Senkel S; Lucas B; Klein-Hitpass L; Ryffel GU
Biochim Biophys Acta; 2005 Dec; 1731(3):179-90. PubMed ID: 16297991
[TBL] [Abstract][Full Text] [Related]
76. An epigenetic screen unmasks metallothioneins as putative contributors to renal cell carcinogenesis.
Alkamal I; Ikromov O; Tölle A; Fuller TF; Magheli A; Miller K; Krause H; Kempkensteffen C
Urol Int; 2015; 94(1):99-110. PubMed ID: 24662736
[TBL] [Abstract][Full Text] [Related]
77. [Transcriptome analyses in renal cell carcinoma. Combination of laser microdissection and microarrays].
Buchner A; Castro M; Hennig A; Popp T; Assmann G; Hofstetter A; Stief C; Zimmermann W
Urologe A; 2007 Sep; 46(9):1170-5. PubMed ID: 17646957
[TBL] [Abstract][Full Text] [Related]
78. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma.
Riss J; Khanna C; Koo S; Chandramouli GV; Yang HH; Hu Y; Kleiner DE; Rosenwald A; Schaefer CF; Ben-Sasson SA; Yang L; Powell J; Kane DW; Star RA; Aprelikova O; Bauer K; Vasselli JR; Maranchie JK; Kohn KW; Buetow KH; Linehan WM; Weinstein JN; Lee MP; Klausner RD; Barrett JC
Cancer Res; 2006 Jul; 66(14):7216-24. PubMed ID: 16849569
[TBL] [Abstract][Full Text] [Related]
79. RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain.
Niehof M; Borlak J
Mol Pharmacol; 2005 Mar; 67(3):604-11. PubMed ID: 15615695
[TBL] [Abstract][Full Text] [Related]
80. Genetic markers in renal cell carcinomas.
McCue PA; Gorstein F
Hum Pathol; 2001 Oct; 32(10):1027-8. PubMed ID: 11679934
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
